2021, Vol. 3, Issue 1, Part G

Background: As the number of people with diabetes grows worldwide, the disease takes an ever-increasing proportion of national health care budgets. Without primary prevention. The diabetes epidemic will continue to grow. Even worse, diabetes is projected to become one of the world’s main disablers and killers within the next twenty-five years. Immediate action is needed to stem the tide of diabetes and to introduce cost-effective treatment strategics to reverse this trend.

Objective: This study aimed to assess the direct cost incurred by diabetic subjects who mere in different income groups in India. as well as to examine the reducing of costs by acing generic drugs instead of branded drugs.

Methods: A prospective study on "diabetic drugs "was carried out for a period of 6 months. This study was undertaken to know the variation between Diabetic Branded drugs and Diabetic generic drugs including other complications of Type 2 diabetes. It was done in the diabetology ward. This is the first study conducted by the department of pharmacy practice. All the patient records of patients prescribed Diabetic drugs during the study period were noted down using a standard data entry format. Data regarding the duration of the study, the reason for admission, various clinical conditions for which drugs were prescribed, drugs prescribed, Cost of prescribed drugs. Generic ingredients of the drugs, and its generic drugs, etc., were analyzed.

Results: There is a significant cost savings between branded and generic drugs for the same formulation for diabetics with other complications. The Percentage cost savings ranges from 40% to 76% on the generic drugs in comparison with the branded drugs.

Conclusion: The economic burden on diabetic drugs can be reduced in middle class families by using generic drugs and it also help poor families to purchase the diabetes drugs in low cost.